Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has been successfully applied as an identification procedure in clinical microbiology and has been widely used in routine laboratory practice because of its economical and diagnostic benefits. The range of applications of MALDI-TOF MS has been growing constantly, from rapid species identification to labor-intensive proteomic studies of bacterial physiology. The purpose of this review is to summarize the contribution of the studies already performed with MALDI-TOF MS concerning antibiotic resistance and to analyze future perspectives in this field. We believe that current research should continue in four main directions, including the detection of antibiotic modifications by degrading enzymes, the detection of resistance mechanism determinants through proteomic studies of multiresistant bacteria, and the analysis of modifications of target sites, such as ribosomal methylation. The quantification of antibiotics is suggested as a new approach to study influx and efflux in bacterial cells. The results of the presented studies demonstrate that MALDI-TOF MS is a relevant tool for the detection of antibiotic resistance and opens new avenues for both clinical and experimental microbiology.

Department of Microbiology Faculty of Medicine and University Hospital in Plzeň Charles University Prague Plzeň Czech Republic

Zobrazit více v PubMed

Seng P, Rolain J-M, Fournier PE, La Scola B, Drancourt M, Raoult D. 2010. MALDI-TOF-mass spectrometry applications in clinical microbiology. Future Microbiol. 5:1733–1754 PubMed

Wieser A, Schneider L, Jung J, Schubert S. 2012. MALDI-TOF MS in microbiological diagnostics—identification of microorganisms and beyond. Appl. Microbiol. Biotechnol. 93:965–974 PubMed

Livermore DM. 2012. Fourteen years in resistance. Int. J. Antimicrob. Agents 39:283–294 PubMed

Nordmann P, Dortet L, Poirel L. 2012. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol. Med. 18:263–272 PubMed

Hrabák J, Niemczyková J, Chudácková E, Fridrichová M, Studentová V, Cervená D, Urbásková P, Zemlicková H. 2011. KPC-2-producing Klebsiella pneumoniae isolated from a Czech patient previously hospitalized in Greece and in vivo selection of colistin resistance. Folia Microbiol. (Praha) 56:361–365 PubMed

Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. 2012. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin. Microbiol. Rev. 25:682–707 PubMed PMC

Bush K, Jacoby GA, Medeiros AA. 1995. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211–1233 PubMed PMC

Shakil S, Khan R, Zarrilli R, Khan AU. 2008. Aminoglycosides versus bacteria—a description of the action, resistance mechanism, and nosocomial battleground. J. Biomed. Sci. 15:5–14 PubMed

Smith CA, Baker EN. 2002. Aminoglycoside antibiotic resistance by enzymatic deactivation. Curr. Drug Targets Infect. Disord. 2:143–160 PubMed

Nikaido H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67:593–656 PubMed PMC

Zapun A, Contreras-Martel C, Vernet T. 2008. Penicillin-binding proteins and beta-lactam resistance. FEMS Microbiol. Rev. 32:361–385 PubMed

Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. 2009. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin. Microbiol. Rev. 22:664–689 PubMed PMC

Leclercq R, Cantón R, Brown DF, Giske CG, Heisig P, Macgowan AP, Mouton JW, Nordmann P, Rodloff AC, Rossolini GM, Soussy CJ, Steinbakk M, Winstanley TG, Kahlmeter G. 21 October 2011. EUCAST expert rules in antimicrobial susceptibility testing. Clin. Microbiol. Infect. [Epub ahead of print.] doi:10.1111/j.1469-0691.2011.03703.x PubMed DOI

Ledeboer NA, Hodinka RL. 2011. Molecular detection of resistance determinants. J. Clin. Microbiol. 49:S20–S24 doi:10.1128/JCM.00771-11 DOI

Niederman MS. 2009. Treatment options for nosocomial pneumonia due to MRSA. J. Infect. 59(Suppl 1):S25–S31 doi:10.1016/S0163-4453(09)60005-0 PubMed DOI

Grundmann H, Livermore DM, Giske CG, Canton R, Rossolini GM, Campos J, Vatopoulos A, Gniadkowski M, Toth A, Pfeifer Y, Jarlier V, Carmeli Y, CNSE Working Group 2010. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill. 15(46):pii=19711. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19711 PubMed

Tacconelli E. 2009. Methicillin-resistant Staphylococcus aureus: source control and surveillance organization. Clin. Microbiol. Infect. 15(Suppl 7):31–38 PubMed

Buynak JD. 2004. The discovery and development of modified penicillin- and cephalosporin-derived beta-lactamase inhibitors. Curr. Med. Chem. 11:1951–1964 PubMed

Paterson DL, Bonomo RA. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657–686 PubMed PMC

Bush K. 2010. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr. Opin. Microbiol. 13:558–564 PubMed

Nordmann P, Gniadkowski M, Giske CG, Poirel L, Woodford N, Miriagou V, European Network on Carbapenemases 2012. Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin. Microbiol. Infect. 18:432–438 PubMed

Cornaglia G, Akova M, Amicosante G, Cantón R, Cauda R, Docquier JD, Edelstein M, Frère JM, Fuzi M, Galleni M, Giamarellou H, Gniadkowski M, Koncan R, Libisch B, Luzzaro F, Miriagou V, Navarro F, Nordmann P, Pagani L, Peixe L, Poirel L, Souli M, Tacconelli E, Vatopoulos A, Rossolini GM, ESCMID Study Group for Antimicrobial Resistance Surveillance 2007. Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int. J. Antimicrob. Agents 29:380–388 PubMed

Bernabeu S, Poirel L, Nordmann P. 2012. Spectrophotometry-based detection of carbapenemase producers among Enterobacteriaceae. Diagn. Microbiol. Infect. Dis. 74:88–90 PubMed

Girlich D, Poirel L, Nordmann P. 2012. Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J. Clin. Microbiol. 50:477–479 PubMed PMC

Burckhardt I, Zimmermann S. 2011. Using matrix-assisted laser desorption ionization–time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours. J. Clin. Microbiol. 49:3321–3324 PubMed PMC

Hrabák J, Walková R, Studentová V, Chudácková E, Bergerová T. 2011. Carbapenemase activity detection by matrix-assisted laser desorption–ionization time of flight mass spectrometry. J. Clin. Microbiol. 49:3222–3227 PubMed PMC

Pan C, Xu S, Zhou H, Fu Y, Ye M, Zou H. 2007. Recent developments in methods and technology for analysis of biological samples by MALDI-TOF-MS. Anal. Bioanal. Chem. 387:193–204 PubMed

Hrabák J, Studentová V, Walková R, Zemlicková H, Jakubu V, Chudácková E, Gniadkowski M, Pfeifer Y, Perry JD, Wilkinson K, Bergerová T. 2012. Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J. Clin. Microbiol. 50:2441–2443 PubMed PMC

Kempf M, Bakour S, Flaudrops C, Berrazeg M, Brunel JM, Drissi M, Mesli E, Touati A, Rolain JM. 2012. Rapid detection of carbapenem resistance in Acinetobacter baumannii using matrix-assisted laser desorption ionization-time of flight mass spectrometry. PLoS One 7:e31676 doi:10.1371/journal.pone.0031676 PubMed DOI PMC

Sparbier K, Schubert S, Weller U, Boogen C, Kostrzewa M. 2012. Matrix-assisted laser desorption ionization–time of flight mass spectrometry-based functional assay for rapid detection of resistance against β-lactam antibiotics. J. Clin. Microbiol. 50:927–937 PubMed PMC

Hooff GP, van Kampen JJ, Meesters RJ, van Belkum A, Goessens WH, Luider TM. 2012. Characterization of β-lactamase enzyme activity in bacterial lysates using MALDI-mass spectrometry. J. Proteome Res. 11:79–84 PubMed

Bonnin RA, Naas T, Poirel L, Nordmann P. 2012. Phenotypic, biochemical, and molecular techniques for detection of metallo-β-lactamase NDM in Acinetobacter baumannii. J. Clin. Microbiol. 50:1419–1421 PubMed PMC

Kirpekar F, Douthwaite S, Roepstorff P. 2000. Mapping posttranscriptional modifications in 5S ribosomal RNA by MALDI mass spectrometry. RNA 6:296–306 PubMed PMC

Kehrenberg C, Schwarz S, Jacobsen L, Hansen LH, Vester B. 2005. A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503. Mol. Microbiol. 57:1064–1073 PubMed

Savic M, Lovric J, Tomic TI, Vasiljevic B, Conn GL. 2009. Determination of the target nucleosides for members of two families of 16S rRNA methyltransferases that confer resistance to partially overlapping groups of aminoglycoside antibiotics. Nucleic Acids Res. 37:5420–5431 PubMed PMC

Edwards-Jones V, Claydon MA, Evason DJ, Walker J, Fox AJ, Gordon DB. 2000. Rapid discrimination between methicillin-sensitive and methicillin-resistant Staphylococcus aureus by intact cell mass spectrometry. J. Med. Microbiol. 49:295–300 PubMed

Du Z, Yang R, Guo Z, Song Y, Wang J. 2002. Identification of Staphylococcus aureus and determination of its methicillin resistance by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal. Chem. 74:5487–5491 PubMed

Bernardo K, Pakulat N, Macht M, Krut O, Seifert H, Fleer S, Hünger F, Krönke M. 2002. Identification and discrimination of Staphylococcus aureus strains using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics 2:747–753 PubMed

Shah H, Gharbia S. 2010. Mass spectrometry for microbial proteomics. John Wiley & Sons, Inc., Chichester, United Kingdom

Shah HN, Rajakaruna L, Ball G, Misra R, Al-Shahib A, Fang M, Gharbia SE. 2011. Tracing the transition of methicillin resistance in sub-populations of Staphylococcus aureus, using SELDI-TOF mass spectrometry and artificial neural network analysis. Syst. Appl. Microbiol. 34:81–86 PubMed

Majcherczyk PA, McKenna T, Moreillon P, Vaudaux P. 2006. The discriminatory power of MALDI-TOF mass spectrometry to differentiate between isogenic teicoplanin-susceptible and teicoplanin-resistant strains of methicillin-resistant Staphylococcus aureus. FEMS Microbiol. Lett. 255:233–239 PubMed

Dubska L, Pilatova K, Dolejska M, Bortlicek Z, Frostova T, Literak I, Valik D. 2011. Surface-enhanced laser desorption ionization/time-of-flight (SELDI-TOF) mass spectrometry (MS) as a phenotypic method for rapid identification of antibiotic resistance. Anaerobe 17:444–447 PubMed

Camara JE, Hays FA. 2007. Discrimination between wild-type and ampicillin-resistant Escherichia coli by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal. Bioanal. Chem. 389:1633–1638 PubMed

Schaumann R, Knoop N, Genzel GH, Losensky K, Rosenkranz C, Stîngu CS, Schellenberger W, Rodloff AC, Eschrich K. 2012. A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry. Med. Sci. Monit. 18:MT71–MT77 PubMed PMC

Griffin PM, Price GR, Schooneveldt JM, Schlebusch S, Tilse MH, Urbanski T, Hamilton B, Venter D. 2012. Use of matrix-assisted laser desorption ionization–time of flight mass spectrometry to identify vancomycin-resistant enterococci and investigate the epidemiology of an outbreak. J. Clin. Microbiol. 50:2918–2931 PubMed PMC

Marshall T, Williams KM. 2002. Proteomics and its impact upon biomedical science. Br. J. Biomed. Sci. 59:47–64 PubMed

Radhouani H, Poeta P, Pinto L, Miranda J, Coelho C, Carvalho C, Rodrigues J, López M, Torres M, Vitorino R, Domingues P, Igrejas G. 2010. Proteomic characterization of vanA-containing Enterococcus recovered from seagulls at the Berlengas Natural Reserve, W Portugal. Proteome Sci. 8:48 doi:10.1186/1477-5956-8-48 PubMed DOI PMC

Al-Haroni M, Skaug N, Bakken V, Cash P. 2008. Proteomic analysis of ampicillin-resistant oral Fusobacterium nucleatum. Oral Microbiol. Immunol. 23:36–42 PubMed

Pinto L, Poeta P, Vieira S, Caleja C, Radhouani H, Carvalho C, Vieira-Pinto Themudo P, Torres C, Vitorino R, Domingues P, Igrejas G. 2010. Genomic and proteomic evaluation of antibiotic resistance in Salmonella strains. J. Proteomics 73:1535–1541 PubMed

dos Santos KV, Diniz CG, de Castro Veloso L, de Andrade HM, da Silva Giusta M, da Fonseca Pires S, Santos AV, Apolonio ACM, de Carvalho MAR, de Macedo Farias L. 2010. Proteomic analysis of Escherichia coli with experimentally induced resistance to piperacillin/tazobactam. Res. Microbiol. 161:268–275 PubMed

Sharma P, Kumar B, Gupta Y, Singhal N, Katoch VM, Venkatesan K, Bisht D. 2010. Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis. Proteome Sci. 8:59 doi:10.1186/1477-5956-8-59 PubMed DOI PMC

Rogers PD, Vermitsky JP, Edlind TD, Hilliard GM. 2006. Proteomic analysis of experimentally induced azole resistance in Candida glabrata. J. Antimicrob. Chemother. 58:434–438 PubMed

Davin-Regli A, Bolla JM, James CE, Lavigne JP, Chevalier J, Garnotel E, Molitor A, Pages JM. 2008. Membrane permeability and regulation of drug “influx and efflux” in enterobacterial pathogens. Curr. Drug Targets 9:750–759 PubMed

Drew D, Fröderberg L, Baars L, de Gier JW. 2003. Assembly and overexpression of membrane proteins in Escherichia coli. Biochim. Biophys. Acta 1610:3–10 PubMed

Gröbner S, Linke D, Schütz W, Fladerer C, Madlung J, Autenrieth IB, Witte W, Pfeifer Y. 2009. Emergence of carbapenem-non-susceptible extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany. J. Med. Microbiol. 58:912–922 PubMed

Imperi F, Ciccosanti F, Perdomo A, Tiburzi F, Mancone C, Alonzi T, Ascenzi P, Piacentini M, Visca P, Fimia GM. 2009. Analysis of the periplasmic proteome of Pseudomonas aeruginosa, a metabolically versatile opportunistic pathogen. Proteomics 9:1901–1915 PubMed

Peng X, Xu C, Ren H, Lin X, Wu L, Wang S. 2005. Proteomic analysis of the sarcosine-insoluble outer membrane fraction of Pseudomonas aeruginosa responding to ampicilin, kanamycin, and tetracycline resistance. J. Proteome Res. 4:2257–2265 PubMed

Xu C, Lin X, Ren H, Zhang Y, Wang S, Peng X. 2006. Analysis of outer membrane proteome of Escherichia coli related to resistance to ampicillin and tetracycline. Proteomics 6:462–473 PubMed

Tran AX, Lester ME, Stead CM, Raetz CRH, Maskell DJ, McGrath SC, Cotter RJ, Trent MS. 2005. Resistance to the antimicrobial peptide polymyxin requires myristoylation of Escherichia coli and Salmonella typhimurium lipid A. J. Biol. Chem. 280:28186–28194 PubMed

Yi EC, Hackett M. 2000. Rapid isolation method for lipopolysaccharide and lipid A from Gram-negative bacteria. Analyst 125:651–656 PubMed

Coats SR, To TT, Jain S, Braham PH, Darveau RP. 2009. Porphyromonas gingivalis resistance to polymyxin B is determined by the lipid A 4′-phosphatase, PGN_0524. Int. J. Oral Sci. 1:126–135 PubMed PMC

Beceiro A, Llobet E, Aranda J, Bengoechea JA, Doumith M, Hornsey M, Dhanji H, Chart H, Bou G, Livermore DM, Woodford N. 2011. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob. Agents Chemother. 55:3370–3379 PubMed PMC

Cai JC, Hu YY, Zhang R, Zhou HW, Chen G-X. 2012. Detection of Ompk36 porin loss in Klebsiella spp. by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J. Clin. Microbiol. 50:2179–2182 PubMed PMC

Pusch W, Wurmbach J-H, Thiele H, Kostrzewa M. 2002. MALDI-TOF mass spectrometry-based SNP genotyping. Pharmacogenomics 3:537–548 PubMed

Stürenburg E, Storm N, Sobottka I, Horstkotte MA, Scherpe S, Aepfelbacher M, Müller S. 2006. Detection and genotyping of SHV beta-lactamase variants by mass spectrometry after base-specific cleavage of in vitro-generated RNA transcripts. J. Clin. Microbiol. 44:909–915 PubMed PMC

Ikryannikova LN, Shitikov EA, Zhivankova DG, Il'ina EN, Edelstein MV, Govorun VM. 2008. A MALDI TOF MS-based minisequencing method for rapid detection of TEM-type extended-spectrum beta-lactamases in clinical strains of Enterobacteriaceae. J. Microbiol. Methods 75:385–391 PubMed

Ikryannikova LN, Afanas'ev MV, Akopian TA, Il'ina EN, Kuz'min AV, Larionova EE, Smirnova TG, Chernousova LN, Govorun VM. 2007. Mass-spectrometry based minisequencing method for the rapid detection of drug resistance in Mycobacterium tuberculosis. J. Microbiol. Methods 70:395–405 PubMed

Wang Q, Yue J, Zhang L, Xu Y, Chen J, Zhang M, Zhu B, Wang H, Wang H. 2007. A newly identified 191A/C mutation in the Rv2629 gene that was significantly associated with rifampin resistance in Mycobacterium tuberculosis. J. Proteome Res. 6:4564–4571 PubMed

Malakhova MV, Vereshchagin VA, Il'ina EN, Govorun VM, Zubkov MM, Priputnevich TV, Kisina VI, Kubanova AA. 2006. Analysis of genetic markers of N. gonorrhoeae resistance to beta-lactam antibiotics. Bull. Exp. Biol. Med. 141:610–615 PubMed

Borovskaya AD, Malakhova MV, Vereshchagin VA, Il'ina EN, Govorun VM, Priputnevich TV, Al-Hafagi N, Kubanova AA. 2007. Analysis of the contribution of molecular mechanisms into formation of gonoccocal resistance to tetracycline. Bull. Exp. Biol. Med. 144:432–437 PubMed

Il'ina EN, Malakhova MV, Vereshchagin VA, Govorun VM, Priputnevich TV, Kubanova AA. 2007. Direct evaluation of drug resistance parameters in gonococcus. Bull. Exp. Biol. Med. 144:227–230 PubMed

Malakhova MV, Vereshchagin VA, Il'ina EN, Govorun VM, Filimonova O, Grudinina SA, Sidorenko SV. 2007. MALDI-ToF mass-spectrometry in analysis of genetically determined resistance of Streptococcus pneumoniae to fluoroquinolones. Antibiot. Khimioter. 52:10–17 PubMed

Savinova TA, Il'ina EN, Sidorenko SV. 2010. A mass-spectrometric analysis of genetic markers of S. pneumoniae resistance to beta-lactam antibiotics. Mol. Gen. Mikrobiol. Virusol. 3:16–25 PubMed

Shen J, Deng DJ, Ke Y, Zhang JZ. 2008. Detection of point mutation in an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori. Zhonghua Liu Xing Bing Xue Za Zhi 29:166–172 PubMed

Penno MAS, Ernst M, Hoffmann P. 2009. Optimal preparation methods for automated matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling of low molecular weight proteins and peptides. Rapid Commun. Mass Spectrom. 23:2656–2662 PubMed

Li X, Wu X, Kim JM, Kim SS, Jin J, Li D. 2009. MALDI-TOF-MS analysis of small molecules using modified mesoporous material SBA-15 as assisted matrix. J. Am. Soc. Mass Spectrom. 20:2167–2173 PubMed

Lin P-C, Tseng M-C, Su A-K, Chen Y-J, Lin C-C. 2007. Functionalized magnetic nanoparticles for small-molecule isolation, identification, and quantification. Anal. Chem. 79:3401–3408 PubMed

Werno AM, Christner M, Anderson TP, Murdoch DR. 2012. Differentiation of Streptococcus pneumoniae from nonpneumococcal streptococci of the Streptococcus mitis group by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J. Clin. Microbiol. 50:2863–2867 PubMed PMC

Preferred β-lactone synthesis can explain high rate of false-negative results in the detection of OXA-48-like carbapenemases

Combination of mass spectrometry and DNA sequencing for detection of antibiotic resistance in diagnostic laboratories

Validation of a novel automatic deposition of bacteria and yeasts on MALDI target for MALDI-TOF MS-based identification using MALDI Colonyst robot

Detection of OXA-48-type carbapenemase-producing Enterobacteriaceae in diagnostic laboratories can be enhanced by addition of bicarbonates to cultivation media or reaction buffers

Identification of CMY-2-type cephalosporinases in clinical isolates of Enterobacteriaceae by MALDI-TOF MS